- Home
- MCRB vs ODYS Comparison
MCRB vs ODYS Comparison
Compare MCRB & ODYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- ODYS
- Stock Information
- Founded
- MCRB 2010
- ODYS N/A
- Country
- MCRB United States
- ODYS Israel
- Employees
- MCRB N/A
- ODYS N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- ODYS
- Sector
- MCRB Health Care
- ODYS
- Exchange
- MCRB Nasdaq
- ODYS NYSE
- Market Cap
- MCRB 103.7M
- ODYS 86.1M
- IPO Year
- MCRB 2015
- ODYS N/A
- Fundamental
- Price
- MCRB $12.09
- ODYS $4.88
- Analyst Decision
- MCRB Hold
- ODYS Strong Buy
- Analyst Count
- MCRB 4
- ODYS 1
- Target Price
- MCRB $73.67
- ODYS $10.00
- AVG Volume (30 Days)
- MCRB 107.4K
- ODYS 10.3K
- Earning Date
- MCRB 08-12-2025
- ODYS 08-11-2025
- Dividend Yield
- MCRB N/A
- ODYS N/A
- EPS Growth
- MCRB N/A
- ODYS N/A
- EPS
- MCRB 8.98
- ODYS N/A
- Revenue
- MCRB N/A
- ODYS $5,842,000.00
- Revenue This Year
- MCRB N/A
- ODYS N/A
- Revenue Next Year
- MCRB N/A
- ODYS N/A
- P/E Ratio
- MCRB $1.42
- ODYS N/A
- Revenue Growth
- MCRB N/A
- ODYS 100.27
- 52 Week Low
- MCRB $6.53
- ODYS $4.00
- 52 Week High
- MCRB $30.60
- ODYS $10.80
- Technical
- Relative Strength Index (RSI)
- MCRB 66.74
- ODYS N/A
- Support Level
- MCRB $10.67
- ODYS N/A
- Resistance Level
- MCRB $12.84
- ODYS N/A
- Average True Range (ATR)
- MCRB 1.09
- ODYS 0.00
- MACD
- MCRB 0.34
- ODYS 0.00
- Stochastic Oscillator
- MCRB 85.98
- ODYS 0.00
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About ODYS ODYSIGHT AI INC
Odysight ai Inc is engaged in the development, production, and marketing of Predictive Maintenance (PdM) and Condition Based Monitoring (CBM) technologies, providing visual sensing and AI-based video analytics solutions for critical systems in the aviation, maritime, industrial non-destructing-testing industries, transportation, and energy industries.